RU2007121705A - Антиинфекционные липопептиды - Google Patents

Антиинфекционные липопептиды Download PDF

Info

Publication number
RU2007121705A
RU2007121705A RU2007121705/04A RU2007121705A RU2007121705A RU 2007121705 A RU2007121705 A RU 2007121705A RU 2007121705/04 A RU2007121705/04 A RU 2007121705/04A RU 2007121705 A RU2007121705 A RU 2007121705A RU 2007121705 A RU2007121705 A RU 2007121705A
Authority
RU
Russia
Prior art keywords
amino
composition
composition according
compound
protecting group
Prior art date
Application number
RU2007121705/04A
Other languages
English (en)
Russian (ru)
Inventor
Дилан Кристофер АЛЕКСАНДЕР (US)
Дилан Кристофер АЛЕКСАНДЕР
Ричард Х. БАЛЬТЦ (US)
Ричард Х. БАЛЬТЦ
Пол БРАЙАН (US)
Пол БРАЙАН
ГАЛЬ Мари-Франсуаз КЕФФЕ-ЛЕ (US)
ГАЛЬ Мари-Франсуаз КЕФФЕ-ЛЕ
Саша ДЕКЕЛЬ (US)
Саша ДЕКЕЛЬ
Сяовэй ХЭ (US)
Сяовэй ХЭ
Видья КУЛКАРНИ (US)
Видья КУЛКАРНИ
Кристофер ЛЕЙТЕЙЗЕР (US)
Кристофер ЛЕЙТЕЙЗЕР
Вивиан Пак Воон МИАО (CA)
Вивиан Пак Воон МИАО
Киен Трунг НГУЙЕН (US)
Киен Трунг НГУЙЕН
Ян Бэрри ПАРР (US)
Ян Бэрри ПАРР
Дэниел РИТЦ (CH)
Дэниел РИТЦ
Янчжи ЧЖАН (US)
Янчжи ЧЖАН
Original Assignee
Кьюбист Фармасьютикалз
Кьюбист Фармасьютикалз, Инк
Инк (Us)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Кьюбист Фармасьютикалз, Кьюбист Фармасьютикалз, Инк, Инк (Us) filed Critical Кьюбист Фармасьютикалз
Publication of RU2007121705A publication Critical patent/RU2007121705A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
RU2007121705/04A 2004-11-12 2005-11-11 Антиинфекционные липопептиды RU2007121705A (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US62705604P 2004-11-12 2004-11-12
US60/627,056 2004-11-12
US71070505P 2005-08-23 2005-08-23
US60/710,705 2005-08-23
PCT/US2005/040919 WO2006110185A2 (en) 2004-11-12 2005-11-11 Antiinfective lipopeptides

Publications (1)

Publication Number Publication Date
RU2007121705A true RU2007121705A (ru) 2008-12-20

Family

ID=37087468

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2007121705/04A RU2007121705A (ru) 2004-11-12 2005-11-11 Антиинфекционные липопептиды

Country Status (10)

Country Link
EP (1) EP1814588A2 (enExample)
JP (1) JP2008519848A (enExample)
KR (1) KR20070086038A (enExample)
AU (1) AU2005330517A1 (enExample)
BR (1) BRPI0517830A (enExample)
CA (1) CA2587848A1 (enExample)
IL (1) IL183109A0 (enExample)
NO (1) NO20072634L (enExample)
RU (1) RU2007121705A (enExample)
WO (1) WO2006110185A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2512396C2 (ru) * 2008-12-22 2014-04-10 Кьюбист Фармасьютикалз, Инк. Новые противобактериальные средства для лечения грамположительных инфекций

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2013013760A (es) * 2011-05-26 2014-01-08 Cubist Pharm Inc Composiciones de cb-183, 315 y metodos relacionados.
KR101723649B1 (ko) 2014-10-23 2017-04-06 서울대학교산학협력단 신규한 펩티드 화합물, 이의 생산 방법, 및 이의 용도
CN113061164B (zh) * 2021-03-29 2023-01-10 四川大学 环脂肽类化合物及其在抗类风湿关节炎药物中的应用
WO2023152229A1 (en) 2022-02-09 2023-08-17 Teitur Trophics Aps Novel peptides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0017026A (pt) * 1999-12-15 2003-01-07 Cubist Pharm Inc Lipeptìdeos como agentes antibacterianos
IL150224A0 (en) * 1999-12-15 2002-12-01 Cubist Pharm Inc Lipopeptides and pharmaceutical compositions containing the same
CN1423656A (zh) * 1999-12-15 2003-06-11 卡比斯特制药公司 作为抗菌剂的脂肽
WO2003017924A2 (en) * 2001-08-06 2003-03-06 Cubist Pharmaceuticals, Inc. Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
EP1421097A4 (en) * 2001-08-06 2005-07-06 Cubist Pharm Inc COMPOSITIONS AND METHODS RELATING TO THE BIOSYNTHETIC MULTIGENIC FAMILY OF DAPTOMYCIN

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2512396C2 (ru) * 2008-12-22 2014-04-10 Кьюбист Фармасьютикалз, Инк. Новые противобактериальные средства для лечения грамположительных инфекций

Also Published As

Publication number Publication date
BRPI0517830A (pt) 2008-10-21
KR20070086038A (ko) 2007-08-27
WO2006110185A3 (en) 2007-10-25
AU2005330517A1 (en) 2006-10-19
IL183109A0 (en) 2008-04-13
WO2006110185A2 (en) 2006-10-19
EP1814588A2 (en) 2007-08-08
CA2587848A1 (en) 2006-10-19
JP2008519848A (ja) 2008-06-12
AU2005330517A2 (en) 2006-10-19
NO20072634L (no) 2007-08-09

Similar Documents

Publication Publication Date Title
RU2397168C2 (ru) Производные тиофена в качестве ингибиторов снк 1
RU2327701C2 (ru) Нуклеозидные производные и фармацевтическая композиция, обладающая антивирусной активностью в отношении hcv
MX2025001619A (es) Inhibidor de pde4b y uso del mismo
RU2342367C2 (ru) Ненуклеозидные ингибиторы i обратной транскриптазы, предназначенные для лечения заболеваний, опосредованных вич
NZ531493A (en) Novel depsipeptides and process for preparing same, useful in the treatment of bacterial infection
MX340965B (es) Combinaciones para el tratamiento de enfermedades que involucran la proliferacion celular.
RU2009102252A (ru) Хиноксалинилмакроциклические ингибиторы серинпротеазы вируса гепатита с
TW200510391A (en) Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
EP2368900A3 (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
RU2007123235A (ru) Противоопухолевые соединения
RU2008119842A (ru) Производные триазола в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы-1
RU2009102832A (ru) С-фенил-1-тилоглюцитолы
RU2006118789A (ru) 2-цианопирролидинкарбоксамидное соединение
DE69727956D1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
PE20050420A1 (es) Fenacilo 2-hidroxi-3-diaminoalcanos
RU2007136535A (ru) Пептидомиметические соединения и получение биологически активных производных
RU2450015C2 (ru) Производные аминотиазола и их применение в качестве антибактериальных средств
RU2005105576A (ru) Производные плевромутилина в качестве противомикроюных средств
WO2002089782A3 (en) Dioxanes and uses thereof
JP2004530699A5 (enExample)
RU2003134629A (ru) Соединения цефема
RU2008116674A (ru) Новые циклические пептидные соединения
RU2003130070A (ru) Производные бигуанида
JP2008519848A5 (enExample)
EA200600377A1 (ru) Новая композиция

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20100310